[1] |
CRUPI R, CORDARO M, CUZZOCREA S, et al. Management of traumatic brain injury: from present to future[J]. Antioxidants (Basel), 2020, 9(4):297. |
[2] |
ORTEGA-PÉREZ S, AMAYA-REY M C. Secondary brain injury: a concept analysis[J]. J Neurosci Nurs, 2018, 50(4):220-224. doi: 10.1097/JNN.0000000000000384 |
[3] |
SONG C G, ZHANG Y Z, WU H N, et al. Stem cells: a promising candidate to treat neurological disorders[J]. Neural Regen Res, 2018, 13(7):1294-1304. doi: 10.4103/1673-5374.235085 |
[4] |
DAS M, MAYILSAMY K, MOHAPATRA S S, et al. Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects[J]. Rev Neurosci, 2019, 30(8):839-855. doi: 10.1515/revneuro-2019-0002 |
[5] |
DA SILVA MEIRELLES L, CHAGASTELLES P C, NARDI N B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues[J]. J Cell Sci, 2006, 119(Pt 11): 2204-2213. |
[6] |
LYE K L, NORDIN N, VIDYADARAN S, et al. Mesenchymal stem cells: From stem cells to sarcomas[J]. Cell Biol Int, 2016, 40(6):610-618. doi: 10.1002/cbin.10603 |
[7] |
DEHGHANIAN F, SOLTANI Z, KHAKSARI M. Can mesenchymal stem cells act multipotential in traumatic brain injury?[J]. J Mol Neurosci, 2020, 70(5):677-688. doi: 10.1007/s12031-019-01475-w |
[8] |
HASAN A, DEEB G, RAHAL R, et al. Mesenchymal stem cells in the treatment of traumatic brain injury[J]. Front Neurol, 2017, 8:28. |
[9] |
ADUGNA D G, ARAGIE H, KIBRET A A, et al. Therapeutic application of stem cells in the repair of traumatic brain injury[J]. Stem Cells Cloning, 2022, 15:53-61. |
[10] |
LU D, MAHMOOD A, WANG L, et al. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome[J]. Neuroreport, 2001, 12(3):559-563. doi: 10.1097/00001756-200103050-00025 |
[11] |
MAHMOOD A, LU D, YI L, et al. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats[J]. J Neurosurg, 2001, 94(4):589-595. doi: 10.3171/jns.2001.94.4.0589 |
[12] |
MENG T T, XIAO D F, MUHAMMED A, et al. Anti-inflammatory action and mechanisms of resveratrol[J]. Molecules, 2021, 26(1):229. doi: 10.3390/molecules26010229 |
[13] |
FENG Y, JU Y R, YAN Z J, et al. Resveratrol attenuates autophagy and inflammation after traumatic brain injury by activation of PI3K/Akt/mTOR pathway in rats[J]. Fn, 2022, 60(2):153-164. doi: 10.5114/fn.2022.118184 |
[14] |
WANG C M, GONG Y H, ZHONG Y, et al. The control of anchorage-dependent cell behavior within a hydrogel/microcarrier system in an osteogenic model[J]. Biomaterials, 2009, 30(12):2259-2269. doi: 10.1016/j.biomaterials.2008.12.072 |
[15] |
HUANG H Q, QI X L, CHEN Y H, et al. Thermo-sensitive hydrogels for delivering biotherapeutic molecules: a review[J]. Saudi Pharm J, 2019, 27(7):990-999. doi: 10.1016/j.jsps.2019.08.001 |
[16] |
HU Y L, SHIN Y, PARK S, et al. Multifunctional oxidized Succinoglycan/Poly (N-isopropylacrylamide-co-acrylamide) hydrogels for drug delivery[J]. Polymers, 2022, 15(1):122. doi: 10.3390/polym15010122 |
[17] |
TORRES-ORTEGA P V, DEL CAMPO-MONTOYA R, PLANO D, et al. Encapsulation of MSCs and GDNF in an injectable nanoreinforced supramolecular hydrogel for brain tissue engineering[J]. Biomacromolecules, 2022, 23(11):4629-4644. doi: 10.1021/acs.biomac.2c00853 |
[18] |
JEONG Y W, KIM H S, THANGAVELU M, et al. Progress in silk fibroin based composite scaffold/hydrogel: silk fibroin/PEG hydrogel for the RPE regeneration a promising biomaterial for clinical application[J]. Front Mater, 2020, 7:305. |
[19] |
MUNOZ J R, STOUTENGER B R, ROBINSON A P, et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice[J]. Proc Natl Acad Sci U S A, 2005, 102(50):18171-18176. doi: 10.1073/pnas.0508945102 |
[20] |
ZHANG R, LIU Y, YAN K, et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury[J]. J Neuroinflammation, 2013, 10:106. |
[21] |
MENGE T, ZHAO Y H, ZHAO J, et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury[J]. Sci Transl Med, 2012, 4(161):161ra150. |
[22] |
BURDICK J A, MAUCK R L, GERECHT S. To serve and protect: hydrogels to improve stem cell-based therapies[J]. Cell Stem Cell, 2016, 18(1):13-15. doi: 10.1016/j.stem.2015.12.004 |
[23] |
YU P P, WANG L, TANG F R, et al. Resveratrol pretreatment decreases ischemic injury and improves neurological function via sonic hedgehog signaling after stroke in rats[J]. Mol Neurobiol, 2017, 54(1):212-226. doi: 10.1007/s12035-015-9639-7 |
[24] |
HOU Y Y, WANG K, WAN W J, et al. Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats[J]. Genes Dis, 2018, 5(3):245-255. doi: 10.1016/j.gendis.2018.06.001 |
[25] |
FUGGETTA M P, BORDIGNON V, COTTARELLI A, et al. Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol[J]. J Exp Clin Cancer Res, 2016, 35(1):118. doi: 10.1186/s13046-016-0398-8 |
[26] |
沈阳辉, 朱鹏立. 白藜芦醇在动脉粥样硬化中的抗炎作用机制探讨[J]. 国外医学(老年医学分册), 2006, 27(4):169-172. |
[27] |
GU T Y, WANG N M, WU T, et al. Antioxidative stress mechanisms behind resveratrol: a multidimensional analysis[J]. J Food Qual, 2021, 2021:5571733. |
[28] |
BROTONS-CANTO A, GONZALEZ-NAVARRO C J, GURREA J, et al. Zein nanoparticles improve the oral bioavailability of resveratrol in humans[J]. J Drug Deliv Sci Technol, 2020, 57:101704. doi: 10.1016/j.jddst.2020.101704 |
[29] |
MACHADO N D, GUTIÉRREZ G, MATOS M, et al. Preservation of the antioxidant capacity of resveratrol via encapsulation in niosomes[J]. Foods, 2021, 10(5):988. doi: 10.3390/foods10050988 |